CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy · Terms of Service · Privacy FAQ

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Gandeeva Therapeutics›
Library
Gandeeva Therapeutics

Gandeeva Therapeutics

Gandeeva Therapeutics uses structural imaging to develop precision medicines and support drug discovery.

Burnaby, BC, CA🇨🇦
Founded
2021
Loading
Overview
Compare
Fundraising
Employees
Library

Gandeeva Therapeutics - Library

Official pages and third-party coverage in one index.

gandeeva.com·38 items across 37 mapped pages · Crawled Oct 2, 2026·

Topics

Publication type

Content origin
Row density

Official pages and third-party coverage in one index

Product

6 pages
  1. CRYO-CADD/our-platform/cryo-cadd

    CRYO-CADD TM CRYO-CADDTM powers Gandeeva’s drug discovery engine through a rapid iterative cycle that generates structural insights. CRYO-CADDTM enables rapid hit-to-lead optimization. In this process, chemical scaffolds are optimized via iterative structure-guided design, a cycle we repeat until we optimize a development candidate. By using high-throughput cryo-EM to generate the structures that guide the CRYO-CADDTM […]

  2. HYPERFOCUS/our-platform/hyperfocus

    HYPERFOCUSTM HYPERFOCUSTM drives computational and empirical identification of druggable targets prioritized by SPOTLIGHTTM and validated by cryo-EM. Computational modeling without structural validation can lead to compound design dead-ends. HYPERFOCUSTM combines real experimental data with fragment libraries and virtual screening to refine and confirm our predictions. HYPERFOCUSTM enables us to create detailed structural models of potential […]

  3. Our Platform/our-platform

    Our platform identifies druggable transient protein interactions to enable the custom design of precision molecular glues.

  4. Pipeline/pipeline

Blog

6 pages
  1. A paradigm shift in structural biology/a-paradigm-shift-in-structural-biology
  2. Bayer's Venture Arm Finds Another Startup Worth Leaping For/bayers-venture-arm-finds-another-startup-worth-leaping-for
  3. Gandeeva Therapeutics and Cryogenic Electron Microscopy/gandeeva-therapeutics-and-cryogenic-electron-microscopy%EF%BF%BC
  4. Omicron mutations help it evade antibodies/omicron-mutations-help-it-evade-antibodies

Press

6 pages
  1. Cryo-EM focused biotech from longtime NIH veteran secures $40M backing from Bayer in Series A/cryo-em-focused-biotech-from-longtime-nih-veteran-secures-40m-backing-from-bayer-in-series-a
  2. Gandeeva Raises $40M in Series A Funding to Develop Novel Therapies Based on Precision Imaging of Protein-Drug Interactions/gandeeva-raises-40m-in-series-a-funding

    VANCOUVER, British Columbia–(BUSINESS WIRE) Gandeeva Therapeutics, a precision biotechnology company harnessing the power of cryogenic electron microscopy (cryo-EM) and machine learning to develop novel therapeutics at an accelerated pace, today announced it has raised US$40 million in Series A funding led by Lux Capital and Leaps by Bayer, with participation from Obvious Ventures, Amgen Ventures, […]

  3. Gandeeva Raises $40M to Zoom in on Biomolecules – and Create New Drugs/gandeeva-raises-40m-to-zoom-in-on-biomolecules-and-create-new-drugs
  4. Gandeeva Therapeutics: A differentiated drug discovery platform (Life Sciences 2022)/biv-life-sciences-2022

Careers & Hiring

3 pages
  1. Careers/careers

    Careers We are seeking creative leaders, problem solvers, and curious innovators. Gandeeva Therapeutics offers a flexible, equitable, inclusive, and respectful work environment in which each individual employee has opportunities for inspiration, development, and growth. Join our interdisciplinary team and build a meaningful career in the drug development industry. Our mission We aim to revolutionize the […]

  2. Jobs Archive/jobs
  3. Scientist I, Protein Biophysics and Biochemistry/jobs/scientist-i-protein-biophysics-and-biochemistry

    Gandeeva Therapeutics Inc. is a biotechnology company located in Metro Vancouver, BC, that seeks to harness the transformative power of cryo-EM technology to design better drugs. Our methods overcome limitations in the use of X-ray crystallography for drug design and avoid discovery dead ends that can arise from the use of computational docking methods in the absence […]

Team

6 pages
  1. Chas Bountra, Ph.D./chas-bountra-ph-d

    Pro-Vice Chancellor for Innovation and Professor of Translational Medicine, Oxford University.

  2. David Karp/david-karp

    Chief Financial Officer

  3. Dermot Kelleher, M.D./dermot-kelleher-m-d

    Dean, Faculty of Medicine and Vice-President, Health, University of British Columbia.

  4. Rohan Ganesh/rohan-ganesh

    Board Observer

Contact

1 page
  1. Contact/contact

    Contact Us Vancouver, British [email protected]    Gandeeva Therapeutics, Inc. 600 Stewart Street, Suite 300Seattle, WA 98101   Canadian Operations: 3885 Henning DriveBurnaby, British ColumbiaCanada  V5C 6N5  [email protected]

Homepage

1 page
  1. Homepage/

    Gandeeva Therapeutics is a precision medicine company leveraging cryo-EM and machine learning for drug discovery.

Privacy

6 pages
  1. Cookie Policy (CA)/cookie-policy-ca
  2. Cookie Policy (EU)/cookie-policy-eu
  3. Privacy Policy/privacy-policy

    Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Lorem ipsum dolor […]

  4. Privacy Statement (CA)/privacy-statement-ca

    This privacy statement was last changed on March 7, 2022, last checked on April 19, 2022, and applies to citizens and legal permanent residents of Canada.

Terms & Conditions

2 pages
  1. Disclaimer/disclaimer
  2. Terms & conditions/terms-conditions

Not yet classified

1 page
  1. gandeeva.com/

    Gandeeva Therapeutics is a precision medicine company leveraging cryo-EM and machine learning for drug discovery.